Leaps by Bayer has led the seed round for Edifice Health, which spun out of Stanford University and also attracted Ahren Innovation Capital.
Edifice Health, a US-based immunology technology developer spun out of Stanford University’s 1,000 Immunomes Project, has collected $12m in a seed round backed by patient capital fund Ahren Innovation Capital.
Leaps by Bayer, the corporate venturing arm of chemicals and pharmaceutical producer Bayer, led the round, which also featured Human Longevity and Performance Impact Venture Fund, Longevity Incubator Fund, Summer Venture Capital, Carlyle Global Advisors, M4 Capital and Better Food Ventures.
Pharmaceutical firm Taisho Pharmaceutical and Paladin…
